| 1. Khan MF, Azad CS, Kumar A, Saini M, Narula AK, Jain S.. (2016) Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking., 26 (8): [PMID:26965864] [10.1016/j.bmcl.2016.03.003] |
| 2. De Vita D, Moraca F, Zamperini C, Pandolfi F, Di Santo R, Matheeussen A, Maes L, Tortorella S, Scipione L.. (2016) In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51., 113 [PMID:26922226] [10.1016/j.ejmech.2016.02.028] |
| 3. Pace JR, DeBerardinis AM, Sail V, Tacheva-Grigorova SK, Chan KA, Tran R, Raccuia DS, Wechsler-Reya RJ, Hadden MK.. (2016) Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic., 59 (8): [PMID:27014922] [10.1021/acs.jmedchem.5b01718] |
| 4. Lee SY, Perotti A, De Jonghe S, Herdewijn P, Hanck T, Müller CE.. (2016) Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors., 24 (14): [PMID:27265686] [10.1016/j.bmc.2016.05.046] |
| 5. Asada K, Canestrari E, Paroo Z.. (2016) A druggable target for rescuing microRNA defects., 26 (20): [PMID:27641467] [10.1016/j.bmcl.2016.09.019] |
| 6. Belmonte-Reche E, Martínez-García M, Peñalver P, Gómez-Pérez V, Lucas R, Gamarro F, Pérez-Victoria JM, Morales JC.. (2016) Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents., 119 [PMID:27155468] [10.1016/j.ejmech.2016.04.047] |
| 7. Abdeen S, Salim N, Mammadova N, Summers CM, Goldsmith-Pestana K, McMahon-Pratt D, Schultz PG, Horwich AL, Chapman E, Johnson SM.. (2016) Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness., 26 (21): [PMID:27720295] [10.1016/j.bmcl.2016.09.051] |
| 8. Geldenhuys WJ, Yonutas HM, Morris DL, Sullivan PG, Darvesh AS, Leeper TC.. (2016) Identification of small molecules that bind to the mitochondrial protein mitoNEET., 26 (21): [PMID:27687671] [10.1016/j.bmcl.2016.09.009] |
| 9. Ogawa H, Iwasaki A, Sumimoto S, Kanamori Y, Ohno O, Iwatsuki M, Ishiyama A, Hokari R, Otoguro K, O̅mura S, Suenaga K.. (2016) Janadolide, a Cyclic Polyketide-Peptide Hybrid Possessing a tert-Butyl Group from an Okeania sp. Marine Cyanobacterium., 79 (7): [PMID:27359053] [10.1021/acs.jnatprod.6b00171] |
| 10. Ismail, Kuthati B, Thalari G, Bommarapu V, Mulakayala C, Chitta SK, Mulakayala N.. (2017) Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3'-indoline]-2',4(3H)-diones and their evaluation for anticancer activity., 27 (6): [PMID:28216402] [10.1016/j.bmcl.2017.01.088] |
| 11. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK.. (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development., 118 (2): [PMID:20829430] [10.1093/toxsci/kfq269] |
| 12. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
| 13. Yang L, Ma X, Yuan C, He Y, Li L, Fang S, Xia W, He T, Qian S, Xu Z, Li G, Wang Z.. (2017) Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors., 134 [PMID:28415012] [10.1016/j.ejmech.2017.04.010] |
| 14. Belmonte-Reche E, Martínez-García M, Guédin A, Zuffo M, Arévalo-Ruiz M, Doria F, Campos-Salinas J, Maynadier M, López-Rubio JJ, Freccero M, Mergny JL, Pérez-Victoria JM, Morales JC.. (2018) G-Quadruplex Identification in the Genome of Protozoan Parasites Points to Naphthalene Diimide Ligands as New Antiparasitic Agents., 61 (3): [PMID:29323491] [10.1021/acs.jmedchem.7b01672] |
| 15. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 16. Giroud M, Kuhn B, Saint-Auret S, Kuratli C, Martin RE, Schuler F, Diederich F, Kaiser M, Brun R, Schirmeister T, Haap W.. (2018) 2 H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design., 61 (8): [PMID:29590751] [10.1021/acs.jmedchem.7b01870] |
| 17. Schnekenburger M, Goffin E, Lee JY, Jang JY, Mazumder A, Ji S, Rogister B, Bouider N, Lefranc F, Miklos W, Mathieu V, de Tullio P, Kim KW, Dicato M, Berger W, Han BW, Kiss R, Pirotte B, Diederich M.. (2017) Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines., 60 (11): [PMID:28475330] [10.1021/acs.jmedchem.7b00533] |
| 18. Gudisela MR, Srinivasu N, Mulakayala C, Bommu P, Rao MVB, Mulakayala N.. (2017) Design, synthesis and anticancer activity of N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives., 27 (17): [PMID:28756024] [10.1016/j.bmcl.2017.07.029] |
| 19. Zheng HC, Lu Y, Chen DF.. (2018) Anticomplement compounds from Polygonum chinense., 28 (9): [PMID:29631958] [10.1016/j.bmcl.2018.03.079] |
| 20. Kuhrt D, Ejaz SA, Afzal S, Khan SU, Lecka J, Sévigny J, Ehlers P, Spannenberg A, Iqbal J, Langer P.. (2017) Chemoselective synthesis and biological evaluation of arylated 2-(Trifluoromethyl) quinolines as nucleotide pyrophosphatase (NPPs) inhibitors., 138 [PMID:28735213] [10.1016/j.ejmech.2017.07.017] |
| 21. Teske KA, Hadden MK.. (2017) Methyllysine binding domains: Structural insight and small molecule probe development., 136 [PMID:28478342] [10.1016/j.ejmech.2017.04.047] |
| 22. Venkatraj M, Salado IG, Heeres J, Joossens J, Lewi PJ, Caljon G, Maes L, Van der Veken P, Augustyns K.. (2018) Novel triazine dimers with potent antitrypanosomal activity., 143 [PMID:29197735] [10.1016/j.ejmech.2017.11.075] |
| 23. Kim TK, Kim JE, Youn UJ, Han SJ, Kim IC, Cho CG, Yim JH.. (2018) Total Syntheses of Lobaric Acid and Its Derivatives from the Antarctic Lichen Stereocaulon alpinum., 81 (6): [PMID:29878768] [10.1021/acs.jnatprod.8b00227] |
| 24. Kwak SH, Shin S, Lee JH, Shim JK, Kim M, Lee SD, Lee A, Bae J, Park JH, Abdelrahman A, Müller CE, Cho SK, Kang SG, Bae MA, Yang JY, Ko H, Goddard WA, Kim YC.. (2018) Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells., 151 [PMID:29649742] [10.1016/j.ejmech.2018.03.023] |
| 25. Pedron J, Boudot C, Hutter S, Bourgeade-Delmas S, Stigliani JL, Sournia-Saquet A, Moreau A, Boutet-Robinet E, Paloque L, Mothes E, Laget M, Vendier L, Pratviel G, Wyllie S, Fairlamb A, Azas N, Courtioux B, Valentin A, Verhaeghe P.. (2018) Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study., 155 [PMID:29885575] [10.1016/j.ejmech.2018.06.001] |
| 26. Rondanin R, Fochi S, Baruchello R, Bernardi T, Oliva P, Semeraro F, Simoni D, Giannini G.. (2017) Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors., 27 (18): [PMID:28811133] [10.1016/j.bmcl.2017.08.013] |
| 27. Blaazer AR, Singh AK, de Heuvel E, Edink E, Orrling KM, Veerman JJN, van den Bergh T, Jansen C, Balasubramaniam E, Mooij WJ, Custers H, Sijm M, Tagoe DNA, Kalejaiye TD, Munday JC, Tenor H, Matheeussen A, Wijtmans M, Siderius M, de Graaf C, Maes L, de Koning HP, Bailey DS, Sterk GJ, de Esch IJP, Brown DG, Leurs R.. (2018) Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity., 61 (9): [PMID:29672041] [10.1021/acs.jmedchem.7b01670] |
| 28. Hailu GS, Robaa D, Forgione M, Sippl W, Rotili D, Mai A.. (2017) Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives., 60 (12): [PMID:28241112] [10.1021/acs.jmedchem.6b01595] |
| 29. Pompermaier L, Heiss EH, Alilou M, Mayr F, Monizi M, Lautenschlaeger T, Schuster D, Schwaiger S, Stuppner H.. (2018) Dihydrochalcone Glucosides from the Subaerial Parts of Thonningia sanguinea and Their in Vitro PTP1B Inhibitory Activities., 81 (9): [PMID:30207720] [10.1021/acs.jnatprod.8b00450] |
| 30. Pettersen D, Fjellström O.. (2018) Small molecule modulators of PCSK9 - A literature and patent overview., 28 (7): [PMID:29519739] [10.1016/j.bmcl.2018.02.046] |
| 31. Zhang H, Collins J, Nyamwihura R, Ware S, Kaiser M, Ogungbe IV.. (2018) Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent., 28 (9): [PMID:29609908] [10.1016/j.bmcl.2018.03.039] |
| 32. Salado IG, Baán A, Verdeyen T, Matheeussen A, Caljon G, Van der Veken P, Kiekens F, Maes L, Augustyns K.. (2018) Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives., 151 [PMID:29604541] [10.1016/j.ejmech.2018.03.048] |
| 33. Cogo J, Cantizani J, Cotillo I, Sangi DP, Corrêa AG, Ueda-Nakamura T, Filho BPD, Martín JJ, Nakamura CV.. (2018) Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents., 26 (14): [PMID:30100019] [10.1016/j.bmc.2018.06.033] |
| 34. West RA, O'Doherty OG, Askwith T, Atack J, Beswick P, Laverick J, Paradowski M, Pennicott LE, Rao SPS, Williams G, Ward SE.. (2017) African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase., 141 [PMID:29107420] [10.1016/j.ejmech.2017.09.067] |
| 35. Lee SY, Müller CE.. (2017) Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors., 8 (5): [PMID:30108800] [10.1039/C7MD00015D] |
| 36. Woodring JL, Behera R, Sharma A, Wiedeman J, Patel G, Singh B, Guyett P, Amata E, Erath J, Roncal N, Penn E, Leed SE, Rodriguez A, Sciotti RJ, Mensa-Wilmot K, Pollastri MP.. (2018) Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation., 9 (10): [PMID:30344906] [10.1021/acsmedchemlett.8b00245] |
| 37. Channar PA, Afzal S, Ejaz SA, Saeed A, Larik FA, Mahesar PA, Lecka J, Sévigny J, Erben MF, Iqbal J.. (2018) Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile., 156 [PMID:30015078] [10.1016/j.ejmech.2018.07.002] |
| 38. Fersing C, Boudot C, Pedron J, Hutter S, Primas N, Castera-Ducros C, Bourgeade-Delmas S, Sournia-Saquet A, Moreau A, Cohen A, Stigliani JL, Pratviel G, Crozet MD, Wyllie S, Fairlamb A, Valentin A, Rathelot P, Azas N, Courtioux B, Verhaeghe P, Vanelle P.. (2018) 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases., 157 [PMID:30092366] [10.1016/j.ejmech.2018.07.064] |
| 39. El-Gamal MI, Ullah S, Zaraei SO, Jalil S, Zaib S, Zaher DM, Omar HA, Anbar HS, Pelletier J, Sévigny J, Iqbal J.. (2019) Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase., 181 [PMID:31382118] [10.1016/j.ejmech.2019.07.063] |
| 40. Xin W, Li Z, Wang Q, Du J, Zhu M, Zhou H.. (2020) Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors., 185 [PMID:31732256] [10.1016/j.ejmech.2019.111827] |
| 41. Paulsen B, Fredriksen KA, Petersen D, Maes L, Matheeussen A, Naemi AO, Scheie AA, Simm R, Ma R, Wan B, Franzblau S, Gundersen LL.. (2019) Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes., 27 (4): [PMID:30638761] [10.1016/j.bmc.2019.01.002] |
| 42. Semreen MH, El-Gamal MI, Ullah S, Jalil S, Zaib S, Anbar HS, Lecka J, Sévigny J, Iqbal J.. (2019) Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors., 27 (13): [PMID:31088715] [10.1016/j.bmc.2019.04.031] |
| 43. Pedron J, Boudot C, Brossas JY, Pinault E, Bourgeade-Delmas S, Sournia-Saquet A, Boutet-Robinet E, Destere A, Tronnet A, Bergé J, Bonduelle C, Deraeve C, Pratviel G, Stigliani JL, Paris L, Mazier D, Corvaisier S, Since M, Malzert-Fréon A, Wyllie S, Milne R, Fairlamb AH, Valentin A, Courtioux B, Verhaeghe P.. (2020) New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi., 11 (4): [PMID:32292551] [10.1021/acsmedchemlett.9b00566] |
| 44. Antoszczak M, Steverding D, Sulik M, Janczak J, Huczyński A.. (2019) Anti-trypanosomal activity of doubly modified salinomycin derivatives., 173 [PMID:30986574] [10.1016/j.ejmech.2019.03.061] |
| 45. de Heuvel E, Singh AK, Boronat P, Kooistra AJ, van der Meer T, Sadek P, Blaazer AR, Shaner NC, Bindels DS, Caljon G, Maes L, Sterk GJ, Siderius M, Oberholzer M, de Esch IJP, Brown DG, Leurs R.. (2019) Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)., 27 (18): [PMID:31378593] [10.1016/j.bmc.2019.06.026] |
| 46. Li J, Ge Y, Huang JX, Strømgaard K, Zhang X, Xiong XF.. (2020) Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery., 63 (10): [PMID:31841625] [10.1021/acs.jmedchem.9b01452] |
| 47. Xu S, Luo S, Zhu Z, Xu J.. (2019) Small molecules as inhibitors of PCSK9: Current status and future challenges., 162 [PMID:30448414] [10.1016/j.ejmech.2018.11.011] |
| 48. Fersing C, Basmaciyan L, Boudot C, Pedron J, Hutter S, Cohen A, Castera-Ducros C, Primas N, Laget M, Casanova M, Bourgeade-Delmas S, Piednoel M, Sournia-Saquet A, Belle Mbou V, Courtioux B, Boutet-Robinet É, Since M, Milne R, Wyllie S, Fairlamb AH, Valentin A, Rathelot P, Verhaeghe P, Vanelle P, Azas N.. (2019) Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity., 10 (1): [PMID:30655943] [10.1021/acsmedchemlett.8b00347] |
| 49. Palanichamy K, Joshi A, Mehmetoglu-Gurbuz T, Bravo MF, Shlain MA, Schiro F, Naeem Y, Garg H, Braunschweig AB.. (2019) Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors., 62 (8): [PMID:30925051] [10.1021/acs.jmedchem.9b00142] |
| 50. Stevens M, Abdeen S, Salim N, Ray AM, Washburn A, Chitre S, Sivinski J, Park Y, Hoang QQ, Chapman E, Johnson SM.. (2019) HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules., 29 (9): [PMID:30852084] [10.1016/j.bmcl.2019.02.028] |
| 51. Bouchet S, Linot C, Ruzic D, Agbaba D, Fouchaq B, Roche J, Nikolic K, Blanquart C, Bertrand P.. (2019) Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling., 10 (6): [PMID:31223439] [10.1021/acsmedchemlett.8b00440] |
| 52. Hulpia F, Campagnaro GD, Scortichini M, Van Hecke K, Maes L, de Koning HP, Caljon G, Van Calenbergh S.. (2019) Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity., 164 [PMID:30677668] [10.1016/j.ejmech.2018.12.050] |
| 53. Laev SS, Salakhutdinov NF, Lavrik OI.. (2016) Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential., 24 (21): [PMID:27687971] [10.1016/j.bmc.2016.09.045] |
| 54. Behnam MA, Nitsche C, Boldescu V, Klein CD.. (2016) The Medicinal Chemistry of Dengue Virus., 59 (12): [PMID:26771861] [10.1021/acs.jmedchem.5b01653] |
| 55. Park JH, Williams DR, Lee JH, Lee SD, Lee JH, Ko H, Lee GE, Kim S, Lee JM, Abdelrahman A, Müller CE, Jung DW, Kim YC.. (2016) Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion., 59 (16): [PMID:27427902] [10.1021/acs.jmedchem.5b01690] |
| 56. Tian M, Abdelrahman A, Baqi Y, Fuentes E, Azazna D, Spanier C, Densborn S, Hinz S, Schmid R, Müller CE.. (2020) Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists., 63 (11): [PMID:32345019] [10.1021/acs.jmedchem.0c00435] |
| 57. Voss S, Nitsche C.. (2020) Inhibitors of the Zika virus protease NS2B-NS3., 30 (5): [PMID:31980339] [10.1016/j.bmcl.2020.126965] |
| 58. Dowarah J, Singh VP.. (2020) Anti-diabetic drugs recent approaches and advancements., 28 (5): [PMID:32008883] [10.1016/j.bmc.2019.115263] |
| 59. Zhang H, Collins J, Nyamwihura R, Crown O, Ajayi O, Ogungbe IV.. (2020) Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities., 30 (14): [PMID:32527539] [10.1016/j.bmcl.2020.127217] |
| 60. Hulpia F,Bouton J,Campagnaro GD,Alfayez IA,Mabille D,Maes L,de Koning HP,Caljon G,Van Calenbergh S. (2020) C6-O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents., 188 [PMID:31931339] [10.1016/j.ejmech.2019.112018] |
| 61. Franco J,Scarone L,Comini MA. (2020) Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency., 189 [PMID:31978782] [10.1016/j.ejmech.2020.112043] |
| 62. Yang LL,Wang HL,Yan YH,Liu S,Yu ZJ,Huang MY,Luo Y,Zheng X,Yu Y,Li GB. (2020) Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery., 192 [PMID:32163813] [10.1016/j.ejmech.2020.112201] |
| 63. Li Q,Groaz E,Rocha-Pereira J,Neyts J,Herdewijn P. (2020) Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides., 195 [PMID:32294613] [10.1016/j.ejmech.2020.112198] |
| 64. Jeffrey JL,Lawson KV,Powers JP. (2020) Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39., 63 (22): [PMID:32786396] [10.1021/acs.jmedchem.0c01044] |
| 65. Yagci S,Gozelle M,Kaya SG,Ozkan Y,Aksel AB,Bakar-Ates F,Dundar Y,Eren G. (2021) Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT., 30 [PMID:33360574] [10.1016/j.bmc.2020.115961] |
| 66. Parveen N,Lin YL,Khan MI,Chou RH,Sun CM,Yu C. (2020) Suramin derivatives play an important role in blocking the interaction between FGF1 and FGFRD2 to inhibit cell proliferation., 206 [PMID:32827875] [10.1016/j.ejmech.2020.112656] |
| 67. Ahmad H,Ullah S,Rahman F,Saeed A,Pelletier J,Sévigny J,Hassan A,Iqbal J. (2020) Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors., 208 [PMID:32883636] [10.1016/j.ejmech.2020.112759] |
| 68. Bouton J,Maes L,Karalic I,Caljon G,Van Calenbergh S. (2021) Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents., 212 [PMID:33385837] [10.1016/j.ejmech.2020.113101] |
| 69. Dukanya null,Shanmugam MK,Rangappa S,Metri PK,Mohan S,Basappa null,Rangappa KS. (2020) Exploring the newer oxadiazoles as real inhibitors of human SIRT2 in hepatocellular cancer cells., 30 (16): [PMID:32631535] [10.1016/j.bmcl.2020.127330] |
| 70. Czerwonka D,Barcelos Y,Steverding D,Cioch A,Huczyński A,Antoszczak M. (2021) Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei., 209 [PMID:33071053] [10.1016/j.ejmech.2020.112900] |
| 71. Fersing C,Boudot C,Castera-Ducros C,Pinault E,Hutter S,Paoli-Lombardo R,Primas N,Pedron J,Seguy L,Bourgeade-Delmas S,Sournia-Saquet A,Stigliani JL,Brossas JY,Paris L,Valentin A,Wyllie S,Fairlamb AH,Boutet-Robinet É,Corvaisier S,Since M,Malzert-Fréon A,Destere A,Mazier D,Rathelot P,Courtioux B,Azas N,Verhaeghe P,Vanelle P. (2020) 8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi., 202 [PMID:32652409] [10.1016/j.ejmech.2020.112558] |
| 72. Fersing C,Boudot C,Paoli-Lombardo R,Primas N,Pinault E,Hutter S,Castera-Ducros C,Kabri Y,Pedron J,Bourgeade-Delmas S,Sournia-Saquet A,Stigliani JL,Valentin A,Azqueta A,Muruzabal D,Destere A,Wyllie S,Fairlamb AH,Corvaisier S,Since M,Malzert-Fréon A,Di Giorgio C,Rathelot P,Azas N,Courtioux B,Vanelle P,Verhaeghe P. (2020) Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties., 206 [PMID:32795774] [10.1016/j.ejmech.2020.112668] |
| 73. Glas C,Dietschreit JCB,Wössner N,Urban L,Ghazy E,Sippl W,Jung M,Ochsenfeld C,Bracher F. (2020) Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations., 206 [PMID:32858418] [10.1016/j.ejmech.2020.112676] |
| 74. Narita K, Suganuma K, Murata T, Kondo R, Satoh H, Watanabe K, Sasaki K, Inoue N, Yoshimura Y.. (2021) Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2,5-diphenyloxazoles., 42 [PMID:34130218] [10.1016/j.bmc.2021.116253] |
| 75. Bouton J, Furquim d'Almeida A, Maes L, Caljon G, Van Calenbergh S, Hulpia F.. (2021) Synthesis and evaluation of 3'-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents., 216 [PMID:33667845] [10.1016/j.ejmech.2021.113290] |
| 76. Li Z, Xin W, Wang Q, Zhu M, Zhou H.. (2021) Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors., 217 [PMID:33725631] [10.1016/j.ejmech.2021.113319] |
| 77. Ullah S, El-Gamal MI, El-Gamal R, Pelletier J, Sévigny J, Shehata MK, Anbar HS, Iqbal J.. (2021) Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents., 217 [PMID:33744686] [10.1016/j.ejmech.2021.113339] |
| 78. Yang F, Su H, Deng J, Mou L, Wang H, Li R, Dai QQ, Yan YH, Qian S, Wang Z, Li GB, Yang L.. (2021) Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates., 225 [PMID:34461505] [10.1016/j.ejmech.2021.113803] |
| 79. Kawaguchi M, Sekimoto E, Ohta Y, Ieda N, Murakami T, Nakagawa H.. (2021) Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors., 64 (13.0): [PMID:34160227] [10.1021/acs.jmedchem.1c00874] |
| 80. Munsimbwe L, Suganuma K, Ishikawa Y, Choongo K, Kikuchi T, Shirakura I, Murata T.. (2022) Benzophenone Glucosides and B-Type Proanthocyanidin Dimers from Zambian Cassia abbreviata and Their Trypanocidal Activities., 85 (1.0): [PMID:34965114] [10.1021/acs.jnatprod.1c00738] |
| 81. Wang M, Tang T, Li R, Huang Z, Ling D, Zheng L, Ding Y, Liu T, Xu W, Zhu F, Min H, Boonhok R, Mao F, Zhu J, Li X, Jiang L, Li J.. (2022) Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety., 65 (5.0): [PMID:35175762] [10.1021/acs.jmedchem.1c01993] |
| 82. Liu Y, Debnath B, Kumar S, Lombard DB, Neamati N.. (2022) Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors., 241 [PMID:35932566] [10.1016/j.ejmech.2022.114623] |
| 83. Wang Y, Chen H, Zha X.. (2022) Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors., 236 [PMID:35436671] [10.1016/j.ejmech.2022.114363] |
| 84. Sherrill LM, Joya EE, Walker A, Roy A, Alhammad YM, Atobatele M, Wazir S, Abbas G, Keane P, Zhuo J, Leung AKL, Johnson DK, Lehtiö L, Fehr AR, Ferraris D.. (2022) Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain., 67 [PMID:35597097] [10.1016/j.bmc.2022.116788] |
| 85. Jędrzejczyk M, Stępczyńska N, Klejborowska G, Podsiad M, Stefańska J, Steverding D, Huczyński A.. (2022) Synthesis and evaluation of antibacterial and trypanocidal activity of derivatives of monensin A., 58 [PMID:34968675] [10.1016/j.bmcl.2021.128521] |
| 86. Mahmood A, Ali Shah SJ, Iqbal J.. (2022) Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorders., 231 [PMID:35123298] [10.1016/j.ejmech.2022.114162] |
| 87. Lee SY, Namasivayam V, Boshta NM, Perotti A, Mirza S, Bua S, Supuran CT, Müller CE.. (2021) Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy., 12 (7.0): [PMID:34355184] [10.1039/D1MD00117E] |
| 88. Arora S, Joshi G, Chaturvedi A, Heuser M, Patil S, Kumar R.. (2022) A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2., 65 (2.0): [PMID:34726055] [10.1021/acs.jmedchem.1c00981] |
| 89. Mahmood A, Villinger A, Iqbal J.. (2022) Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors., 238 [PMID:35660250] [10.1016/j.ejmech.2022.114491] |
| 90. Fiorentino F, Castiello C, Mai A, Rotili D.. (2022) Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5., 65 (14.0): [PMID:35802779] [10.1021/acs.jmedchem.2c00687] |
| 91. Hwu JR, Kapoor M, Gupta NK, Tsay SC, Huang WC, Tan KT, Hu YC, Lyssen P, Neyts J.. (2022) Synthesis and antiviral activities of quinazolinamine-coumarin conjugates toward chikungunya and hepatitis C viruses., 232 [PMID:35176562] [10.1016/j.ejmech.2022.114164] |
| 92. Van Meter EN, Onyango JA, Teske KA.. (2020) A review of currently identified small molecule modulators of microRNA function., 188 [PMID:31931338] [10.1016/j.ejmech.2019.112008] |
| 93. Fu K, Bai Z, Chen L, Ye W, Wang M, Hu J, Liu C, Zhou W.. (2020) Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances., 193 [PMID:32222663] [10.1016/j.ejmech.2020.112221] |
| 94. Jia L, Ma S.. (2016) Recent advances in the discovery of heparanase inhibitors as anti-cancer agents., 121 [PMID:27240275] [10.1016/j.ejmech.2016.05.052] |
| 95. Asakawa Y, Ludwiczuk A.. (2018) Chemical Constituents of Bryophytes: Structures and Biological Activity., 81 (3): [PMID:29019405] [10.1021/acs.jnatprod.6b01046] |
